Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Neurology

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Neurology|November 12, 2003
Statistical issues in neutralizing antibodiesGary Cutter
Neurology|November 6, 2009
Relapses in multiple sclerosis: important or not?Ruth Ann Marrie, Gary Cutter
Neurology|December 10, 2003
Effect of relapses on development of residual deficit in multiple sclerosisFred D Lublin, Monika Baier, Gary Cutter
Neurology|December 3, 2011
Evidence-based guideline update: plasmapheresis in neurologic disordersHenry Kaminski, Gary Cutter, Robert L Ruff, et al.
Neurology|October 28, 2009
A cross-sectional study of bone health in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
Neurology|February 24, 2017
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratificationNicholas Schwab, Tilman Schneider-Hohendorf, Nico Melzer, et al.
Neurology|June 20, 2020
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialAmber Salter, Kaarina Kowalec, Kathryn C Fitzgerald, et al.
Neurology|July 10, 2013
Mortality in patients with multiple sclerosisAntonio Scalfari, Volker Knappertz, Gary Cutter, et al.
Neurology|October 27, 2020
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple SclerosisMarcus W Koch, Jop Mostert, Pavle Repovic, et al.
Neurology|December 8, 2017
Diet quality is associated with disability and symptom severity in multiple sclerosisKathryn C Fitzgerald, Tuula Tyry, Amber Salter, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neurology|November 12, 2003
Statistical issues in neutralizing antibodiesGary Cutter
Neurology|November 6, 2009
Relapses in multiple sclerosis: important or not?Ruth Ann Marrie, Gary Cutter
Neurology|December 10, 2003
Effect of relapses on development of residual deficit in multiple sclerosisFred D Lublin, Monika Baier, Gary Cutter
Neurology|December 3, 2011
Evidence-based guideline update: plasmapheresis in neurologic disordersHenry Kaminski, Gary Cutter, Robert L Ruff, et al.
Neurology|October 28, 2009
A cross-sectional study of bone health in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
Neurology|February 24, 2017
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratificationNicholas Schwab, Tilman Schneider-Hohendorf, Nico Melzer, et al.
Neurology|June 20, 2020
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialAmber Salter, Kaarina Kowalec, Kathryn C Fitzgerald, et al.
Neurology|July 10, 2013
Mortality in patients with multiple sclerosisAntonio Scalfari, Volker Knappertz, Gary Cutter, et al.
Neurology|October 27, 2020
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple SclerosisMarcus W Koch, Jop Mostert, Pavle Repovic, et al.
Neurology|December 8, 2017
Diet quality is associated with disability and symptom severity in multiple sclerosisKathryn C Fitzgerald, Tuula Tyry, Amber Salter, et al.
Pageof 2